Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1502)	1/12/2006 12:24:06 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

PCYC Continues to try closing its Dec.19 downgap.<g> The stock is up today 7% on volume of 765Ks bigcharts.marketwatch.com Dec.19 was when it announced that Xcytrin didn't show statistically significant changes in lung cancer patients with cerebral metastases that were treated for a year combined with radiotherapy, compared with those that were treated with radiation therapy alone. (Although patients taking Xcytrin took 5.4 months longer to progress compared with those receiving radiation alone, that was not considered enough significant difference.) PCYC reportedly has around $3.25 in csh/shr, the insiders hold more than 10% of th stock and it seems that it has a good chance of closing the Dec. downgap.<g> bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (1502)	2/9/2006 3:24:29 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

RNAI Went over the resistance at 4.58 but is having some intraday problems at the 4.70 level.(At 11.55AM & again at 1.40PM) It is still holding above 4.58 (4.64 at present) It may need some late push to see if it can close near its intraday H <g> bigcharts.marketwatch.com The CEO is schedule to present at the Waldorf=Astoria in NY on Feb.15 and its Chief Medical Officer will also participate in the presentation.<g> The Motley Fool also has some comments today on ISIS & RNAI fool.com Bernard